How can the gut microbiome be targeted to fight multidrug-resistant organisms?

Davido, B.; Merrick, B.; Kuijper, E.; Benech, N.; Biehl, L.M.; Corcione, S.; ESCMID (2025)

Article / Letter to editor

The rise of antimicrobial resistance presents a challenge to public health, undermines the efficacy of antibiotics, and compromises the management of infectious diseases. Gut colonisation by multidrug-resistant organisms, such as multidrug-resistant Enterobacterales and vancomycin-resistant enterococci, is associated with increased morbidity and mortality rates, as well as health-care costs. Of late, the role of the gut microbiome in combating colonisation by multidrug-resistant organisms, which could precede invasive infection, has garnered interest. Innovative interventions, including faecal microbiota transplantation, probiotics, phage therapy, and bacterial consortia, represent potential preventive or therapeutic options to counteract colonisation by multidrug-resistant organisms. In this Personal View, we have synthesised the current findings on these interventions and elucidated their potential as solutions to the crisis of antimicrobial resistance.

• All authors: Davido, B.; Merrick, B.; Kuijper, E.; Benech, N.; Biehl, L.M.; Corcione, S.; ESCMID
• Date: 2025-08-05
• Journal: The Lancet Microbe
• Volume: 6
• Issue: 8
• DOI: doi:10.1016/j.lanmic.2024.101063